Skip to main content
Bioventus Inc. (BVS)
NASDAQ: BVS · IEX Real-Time Price · USD
6.38
-0.25 (-3.77%)
At close: May 17, 2024, 4:00 PM
6.65
+0.27 (4.23%)
After-hours: May 17, 2024, 6:43 PM EDT

Bioventus Revenue

Bioventus had revenue of $522.74M in the twelve months ending March 30, 2024, with 1.72% growth year-over-year. Revenue in the quarter ending March 30, 2024 was $129.46M with 8.73% year-over-year growth. In the year 2023, Bioventus had annual revenue of $512.35M with 0.04% growth.

Revenue (ttm)
$522.74M
Revenue Growth
+1.72%
P/S Ratio
0.78
Revenue / Employee
$538,910
Employees
970
Market Cap
408.50M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023512.35M228.00K0.04%
Dec 31, 2022512.12M81.22M18.85%
Dec 31, 2021430.90M109.74M34.17%
Dec 31, 2020321.16M-18.98M-5.58%
Dec 31, 2019340.14M20.96M6.57%
Dec 31, 2018319.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Enhabit 1.04B
Nevro 430.75M
Health Catalyst 296.79M
Esperion Therapeutics 229.74M
ADC Therapeutics 68.62M
C4 Therapeutics 20.04M
Revenue Rankings

BVS News

More News